NEW DELHI – On April 19, the United States once again placed India on its “Priority Watch List” in its 2025 Trade Report, highlighting significant ongoing concerns over intellectual property) ...

Will India’s National IPR Policy help to unleash the country’s innovation potential? Pankaj Soni examines the policy and what more needs to be done Did India put the cart before the horse in ...

The European Union is among India's top trading partners. Commerce between EU nations and India more than doubled between 2003 and 2011 to €79.9 billion, from €28.6 billion; private EU investment ...

On April 13, 1994, while speaking at a ministerial meeting at Marrakesh before the signing of the World Trade Organization Agreement, Pranab Mukherjee representing India, as its commerce minister ...

Shrawan Chopra and Vibhav Mithal of Anand and Anand examine recent judicial developments in India concerning a range of issues including contempt of court, summary judgments, local commissioners and ...

India’s intellectual property rights framework is going through a major transition phase, which is influenced not only by the country's past but also by factors such as technology, worldwide trade, ...

NEW DELHI, (IANS) – India has slipped to the 43rd spot in the US Chamber of Commerce’s latest International Intellectual Property Rights index. India is ranked 43rd out of 55 countries for 2022. It ...

NEW DELHI—India plans to streamline its system for approving and defending intellectual property rights, in a move designed to help international companies that struggle as their drug patent cases get ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. Last month, drug maker Roche withdrew its patents for the ...

Intellectual property (IP) is one of the most contentious issues in modern international trade. It is also one of the key issues for developing and developed markets internally. Disagreements over IP ...

Cheap generic drugs will be protected, groups claim, in a market that is predicted to hit $74 billion in 2020. NEW DELHI -- India's Supreme Court rejected Monday a patent bid by drug giant Novartis ...